MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy by Staff August 15, 2019 August 15, 2019 7 views 7A study has identified a possible second-line treatment for melanoma patients.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post Drug interaction research: Evolution clues next post You Can Now Make Your Own Instagram AR Effects Related Posts Geologists, biologists unearth the atomic fingerprints of cancer May 6, 2024 Simulated chemistry: New AI platform designs tomorrow’s cancer... May 6, 2024 Venus has almost no water: A new study... May 6, 2024 Past and guides future efforts to reduce cancer... May 6, 2024 DDT pollutants found in deep sea fish off... May 6, 2024 The Clues for Cleaner Water May 6, 2024